Bedrocan at CPhI Worldwide 2022
Great that you have found us through CPhI.
A pioneer in the medicinal cannabis industry, Bedrocan began its journey more than two decades ago. We have been a reliable supplier of pharmaceutical-grade medicinal cannabis to the medicinal cannabis program in the Netherlands since its inception in 2003.
Through our expertise in the medicinal cannabis space, we strive to create and be part of robust, sustainable supply chains for cannabis-based patient-first products.
Product offering
Bedrocan currently offers five different strains of dried cannabis flowers in all THC:CBD categories (high-, medium-THC, balanced and CBD-only), with the Bedrocan product accounting for almost 80% of our total production.
Each variety shows a constant composition of the cannabinoids THC and CBD; batch-to-batch, year after year. All our products are produced in accordance with pharmaceutical quality requirements, because our production sites comply with the requirements imposed by EU GMP.
API & raw materials
There is a growing demand for high-quality APIs and raw materials to develop cannabis-based products: dried flowers (flos), full-spectrum extracts and isolates. Through our extensive experience in the state-of-the-art cultivation of cannabis, stable genetics and quality management system, we are well-positioned to meet this demand.
Clinical research
To complement our cannabis plant and analytical research, we support clinical trials and offer our resources and experience to medicinal cannabis research projects worldwide. For more information on clinical research done with Bedrocan products, please contact Dr Mikael Kowal at the Meet Bedrocan page.
Reference works
Please download our corporate brochure and the informative booklet A primer to medicinal cannabis or A clinical primer at the Downloads page.
Subscribe to newsletter
Finally, maybe you want to stay informed about the developments within Bedrocan?
The biggest international pharma industry event CPhI 2022
